Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 39
CEO Mr. Jeff A. Wolf
Address 627 Davis Drive Suite 400, Morrisville, NC 27560
Phone 1.919.240.7133
Website www.heatbio.com

Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Heat Biologics, Inc. -16.62% -32.81%
Omeros Corp. -6.92% 43.72%
FibroGen, Inc. -60.93% -74.43%
iTeos Therapeutics, Inc. 6.60% 12.24%
Graphite Bio, Inc. -9.14% n/a

Statement Summary

as of 4:00 ET PM 09/24/2021
Total Assets (MRQ) 138.8 M
Total Liabilities (MRQ) 8.3 M
Shareholders’ Equity (MRQ) 130.5 M
Total Revenue (Annual) 459.5 K
Net Income (Annual) -6.5 M

Earnings And Estimates

as of 4:00 ET PM 09/24/2021

Current Qtr EPS Estimate -0.29
Current FY EPS Estimate -1.18
Long Term EPS Growth Estimate 1.00
Next Expected Earnings Date //

HTBX vs S&P 500

as of 09/24/2021
Relative To
S&P 500
HTBX
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 09/24/2021
Fiscal Quarter Estimate Actual Surprise
06/2021 -0.31 -0.26 -16.13%
03/2021 -0.27 -0.31 +13.41%
12/2020 -0.35 -0.27 -23.19%
09/2020 -0.23 -0.42 +84.62%
06/2020 -0.56 -0.35 -37.50%
03/2020 -0.70 -0.77 +10.00%
12/2019 -1.00 -0.86 -13.95%
09/2019 -1.00 -1.26 +25.58%

Financial Strength

as of 4:00 ET PM 09/24/2021
Pre-Tax Margin -1.00
Net Margin -89.62
Operating Margin -1.00
Return On Equity -32.81
Return On Assets -29.83
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) n/a

Ratios

as of 4:00 PM ET 09/24/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 1.15
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 5.23
Quick Ratio (MRQ) 37.22
Current Ratio (MRQ) 37.22
Total Debt/Equity (MRQ) 0.01

Short Interest

as of 4:00 PM ET 09/27/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 09/24/2021
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Consensus Estimate $-0.29 $-0.31
# of Estimates 5 5
High Estimate $-0.26 $-0.27
Low Estimate $-0.37 $-0.38
Year Ago EPS $-0.29 $-0.29
Year Over Year Growth Estimate 2.94% 7.84%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-1.18 $-1.22
# of Estimates 5 5
High Estimate $-1.10 $-1.05
Low Estimate $-1.33 $-1.53
Year Ago EPS $-1.61 $-1.18
Year Over Year Growth Estimate -26.96% 3.74%
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.29 $-0.31 $-1.18 $-1.22
# of Estimates 5 5 5 5
High Estimate $-0.26 $-0.27 $-1.10 $-1.05
Low Estimate $-0.37 $-0.38 $-1.33 $-1.53
Year Ago EPS $-0.29 $-0.29 $-1.61 $-1.18
Year Over Year Growth Estimate 2.94% 7.84% -26.96% 3.74%

Insider Information Summary

as of 08/31/2021
% Insiders - 4.30%
% Remaining Total Shares - 95.70%
Current 1 Month
Net Insider Transaction 0.00 -35.00 K
Shares Bought 0.00 0.00
Shares Sold 0.00 35.00 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Ford Logo Lead Graphic

Ford Stock Leaps On $11.4 Billion F-150, Battery Factory Investment Boost

Ford will pump $11.4 billion into three battery plants, as well as an electric F-150 assembly plant, as the carmaker doubles-down on its EV investment shift.

Wall Street Diversity Lead

Tech Leads Stocks Lower, China Cuts Power, Ford Boosts EV Investment - 5 Things You Must Know

Stock futures slump as yields, energy prices soar, China cuts power as global energy crunch intensifies; Powell faces Senate Banking Committee; Ford doubles-down on EV investment; TikTok passes $1 billion users.

The IPO That Never Was: Jim Cramer on Why Endeavor Didn't Go Public

Endeavor Agrees to Buy Sports Gambling Business OpenBet

Sports and entertainment company Endeavor agrees to acquire sports betting engine technology provider OpenBet from Scientific Games for $1.2 billion.

19 france paris sh

Airbnb Benefits From Work at Home, but Delta Holds Risks

The chairman of vacation rental company tells Jim Cramer that adaptability and diversity of listings is key to success.

Benioff: Not a fan of "draconian" software

Salesforce CEO: Facebook Misinformation Is Dangerous

Mark Benioff comments in interview with Jim Cramer

Air Products' Spin Off Versum Materials Begins Trading on the NYSE

Cramer's Mad Money Recap: Tesla, Chevron, Best Buy

Jim Cramer has his eyes on the big investing themes that will drive the market -- and the best stocks.